Runnymede Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Runnymede Capital Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-289	Closed	-$47.9K	–	170
2025 Q1	$47.9K	Buy	289 +29	+11%	+$4.54K	0.05%	133
2024 Q4	$37.6K	Buy	+260	New	+$40.3K	0.03%	141

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Runnymede Capital Advisors's JNJ Position: Q2 2025 in Review

Runnymede Capital Advisors sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 289 shares — an estimated $47.9K sold.

Runnymede Capital Advisors first reported a position in JNJ in Q4 2024 and held it in 2 quarters. The position peaked at $47.9K in Q1 2025. 4,083 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

Runnymede Capital Advisors reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
Runnymede Capital Advisors sold 289 Johnson & Johnson shares in Q2 2025, an estimated $47.9K.
Runnymede Capital Advisors first reported a position in Johnson & Johnson in Q4 2024 and held it in 2 quarters.
Runnymede Capital Advisors's Johnson & Johnson position peaked at $47.9K in Q1 2025.
4,083 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Runnymede Capital Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.